Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study

INTRODUCTION: People living with diabetes in low-resource settings may be at increased hypoglycemia risk due to food insecurity and limited access to glucose monitoring. We aimed to assess hypoglycemia risk associated with sulphonylurea (SU) and insulin therapy in people living with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Niwaha, Anxious J, Rodgers, Lauren R, Carr, Alice L J, Balungi, Priscilla A, Mwebaze, Raymond, Hattersley, Andrew T, Shields, Beverley M, Nyirenda, Moffat J, Jones, Angus G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical care/Education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024213/
https://www.ncbi.nlm.nih.gov/pubmed/35450869
http://dx.doi.org/10.1136/bmjdrc-2021-002714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024213/
https://www.ncbi.nlm.nih.gov/pubmed/35450869
http://dx.doi.org/10.1136/bmjdrc-2021-002714

Ejemplares similares